Differences in in vitro proliferative responsiveness to granulocyte colony-stimulating factor and interleukin 2 of bone marrow cells from mice treated with chemotherapeutic drugs.
暂无分享,去创建一个
[1] J. Gabrilove,et al. Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium , 1989 .
[2] J. Gutterman,et al. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, The New England journal of medicine.
[3] J. Ihle,et al. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Crowther,et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. , 1987, British Journal of Cancer.
[5] H. Nomura,et al. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice , 1987, Infection and immunity.
[6] R. Neta,et al. The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. , 1987, Journal of immunology.
[7] C. Riccardi,et al. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors. , 1987, Journal of immunology.
[8] M. F. Shannon,et al. Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Sugimachi,et al. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. , 1987, Cancer research.
[10] D. Williams,et al. Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. , 1987, The Journal of clinical investigation.
[11] S. Nagata,et al. The chromosomal gene structure and two mRNAs for human granulocyte colony‐stimulating factor. , 1986, The EMBO journal.
[12] V. Kindler,et al. Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Rosenberg,et al. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2 , 1985, The Journal of experimental medicine.
[14] S. Rosenberg,et al. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 , 1984, The Journal of experimental medicine.
[15] W. Fried,et al. EFFECT OF CYCLOPHOSPHAMIDE ON THE HEMATOPOIETIC MICROENVIRONMENTAL FACTORS WHICH INFLUENCE HEMATOPOIETIC STEM CELL PROLIFERATION , 1973, Cell and tissue kinetics.
[16] P. Carbone,et al. Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro. , 1971, Cancer research.
[17] A. Goldin,et al. Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity. , 1970, Cancer research.
[18] S. Asano,et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. , 1989, Blood.
[19] P. Quesenberry,et al. Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. , 1988, Experimental hematology.